Ribavirin and Oxybutynin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ribavirin (ribavirin) and Oxybutynin (oxybutynin). Common drug interactions include cardiac tamponade among females and completed suicide among males.

The phase IV clinical study analyzes what interactions people have when they take Ribavirin and Oxybutynin. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Ribavirin?

Ribavirin has active ingredients of ribavirin. It is often used in hepatitis c. eHealthMe is studying from 78,532 Ribavirin users. Check the latest studies of Ribavirin.

What is Oxybutynin?

Oxybutynin has active ingredients of oxybutynin. It is often used in urge incontinence. eHealthMe is studying from 23,143 Oxybutynin users. Check the latest studies of Oxybutynin.



On Jul, 16, 2026

16 people who take Ribavirin and Oxybutynin together, and have interactions are studied.

Ribavirin and Oxybutynin drug interactions.

What are the common drug interactions of Ribavirin and Oxybutynin, by gender? *:

female:

  1. Cardiac tamponade (fluid accumulates in heart covering)
  2. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  3. Hallucination (an experience involving the perception of something not present)
  4. Sleep disorder
  5. Diarrhoea
  6. Haemorrhoids (a swollen vein or group of veins in the region of the anus)
  7. Rectal haemorrhage (bleeding from anus)

male:

  1. Completed suicide (act of taking one's own life)
  2. Gun shot wound
  3. Myalgia (muscle pain)
  4. Renal impairment (severely reduced kidney function)
  5. Urticaria (rash of round, red welts on the skin that itch intensely)
  6. Balance disorder
  7. Decreased appetite
  8. Diarrhoea
  9. Dizziness
  10. Dyspnoea exertional (breathlessness or shortness of breath)

What are the common drug interactions of Ribavirin and Oxybutynin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Cardiac tamponade (fluid accumulates in heart covering)

30-39:

  1. Focal segmental glomerulosclerosis (scar tissue that forms in parts of the kidney called glomeruli)
  2. Myalgia (muscle pain)
  3. Renal impairment (severely reduced kidney function)
  4. Urticaria (rash of round, red welts on the skin that itch intensely)

40-49:

  1. Blood pressure decreased
  2. Body temperature increased
  3. Delirium (wild excitement)
  4. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  5. Psychotic disorder

50-59:

  1. Completed suicide (act of taking one's own life)
  2. Gun shot wound
  3. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  4. Diarrhoea
  5. Dyspnoea exertional (breathlessness or shortness of breath)
  6. Fatigue (feeling of tiredness)
  7. Haematemesis (vomiting of blood)
  8. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  9. Hallucination (an experience involving the perception of something not present)
  10. Productive cough

60+:

  1. Rash
  2. Balance disorder
  3. Pruritus (severe itching of the skin)
  4. Pruritus generalised (generalized itching)
  5. Pyrexia (fever)
  6. Decreased appetite
  7. Dizziness
  8. Ear infection
  9. Gastric disorder (disease of stomach)
  10. Headache (pain in head)

What are the existing conditions these people have? *

  1. Immunodeficiency Disorders: 3 people, 18.75%
  2. Hiv Infection: 2 people, 12.50%
  3. Drug Dependence: 2 people, 12.50%
  4. Type 1 Diabetes: 1 person, 6.25%
  5. Stress And Anxiety: 1 person, 6.25%
  6. High Blood Pressure: 1 person, 6.25%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 6.25%
  8. Depression: 1 person, 6.25%
  9. Asthma: 1 person, 6.25%
  10. Allergic Rhinitis: 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Ribavirin and Oxybutynin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ribavirin and Oxybutynin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ribavirin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Oxybutynin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ribavirin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Oxybutynin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on ribavirin and oxybutynin (the active ingredients of Ribavirin and Oxybutynin, respectively), and Ribavirin and Oxybutynin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: